Glaucoma Specialists at IOC 2027

Vision loss caused by glaucoma remains a significant public health challenge, making the expertise of glaucoma specialists essential in preventing irreversible damage to the optic nerve. Early diagnosis through advanced imaging techniques, such as optical coherence tomography (OCT) and visual field testing, allows for the timely initiation of treatment strategies that range from medication management to laser procedures like selective laser trabeculoplasty (SLT). Minimally invasive glaucoma surgeries (MIGS) have revolutionized surgical approaches by providing safer, less invasive options that reduce intraocular pressure while minimizing complications.

Continuous innovations in drug delivery, including sustained-release implants and nanoparticle-based therapies, are enhancing treatment efficacy and patient adherence. Artificial intelligence is also playing an increasing role in disease monitoring, enabling automated screening tools that assist in early detection and progression tracking. As research progresses, gene therapies and neuroprotective treatments are emerging as potential future solutions for halting optic nerve degeneration. With glaucoma being one of the leading causes of blindness worldwide, specialists in this field are at the forefront of developing novel interventions that offer long-term protection and improved quality of life for patients.